ArticleFrontiers in physiology2025
Validity of smartwatch-derived estimates of lactate threshold heart rate and pace compared to graded exercise testing.
Article in Frontiers in physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Quantifying exercise intensity through the lactate threshold (LT) is crucial for optimizing athletic training regimes. Traditional methods like maximal lactate steady state and graded exercise testing are valid but invasive and costly. Advances in smartwatch technology offer a non-invasive alternative for monitoring LT, though their measurement protocols and outcomes have been less validated. Methods: This study evaluates the validity of three mainstream smartwatches (Huawei GT Runner®, Garmin Forerunner 265® or 265s®, and Coros Pace3®) in estimating lactate threshold heart rate (LT HR) and pace (LT Pace), comparing these to measurement protocols and results from the modified Dmax method in laboratory standards. One hundred healthy recreational runners underwent indoor graded exercise tests followed by outdoor tests using Huawei (n = 100), Garmin (n = 23), and Coros (n = 17) smartwatches to compare differences in testing protocols and LT HR and LT Pace. Results: The success rates for a single test were 78% for Huawei®, 65.22% for Garmin®, and 47.06% for Coros®. For LT HR, no significant differences were observed between smartwatch and DmaxMod estimates across all devices (p > 0.05). The Huawei® watch showed MAE = 10.66 bpm, MAPE = 6.32%; Garmin®: MAE = 11.44 bpm, MAPE = 7.15%; Coros®: MAE = 8.93 bpm, MAPE = 5.95%. Corresponding Pearson correlation coefficients ranged from r = 0.13 to 0.67, and Conclusion: Smartwatches are capable of providing estimates of LT HR and LT Pace in recreational runners, although they tend to overestimate LT Pace and overall accuracy remains to be improved.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.